Keyphrases
Yeast Product
56%
Glucan
56%
Care Coordination
56%
Multiple Chronic Conditions
56%
Bevacizumab
56%
Vascular Endothelial Growth Factor
44%
Membrane Binding
40%
Primary Care Providers
37%
In Cancer
37%
Therapeutic Efficacy
36%
Patients with Cancer
33%
Monoclonal Antibody
32%
Oncologists
30%
Mindfulness-based Programs
28%
Southeastern US
28%
Manganese Superoxide Dismutase (MnSOD)
28%
Antioxidant System
28%
Mind-body Interventions
28%
Epigenetic Modulation
28%
Knock-in Mouse Model
28%
Superoxide Dismutase 2 (SOD2)
28%
Cancer-related Fatigue
28%
Quality of Life
28%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
28%
Adult Cancer
28%
Advanced Cancer
28%
Patient Perspective
28%
Breast Cancer Patients
28%
Xenograft Model
28%
Subcutaneous Xenograft
28%
Healthcare Provider Perspectives
28%
Gut Microbiome
28%
Thalidomide
28%
Oncology Care
28%
Dietary Factors
28%
Phase I Study
28%
Orthotopic Xenograft Model
28%
Temozolomide
28%
Primary Care
28%
Heart Failure
28%
Randomized Trial
28%
Human Carcinoma
28%
Human Lung Adenocarcinoma
28%
Capecitabine
28%
Dose-limiting Toxicity
22%
Vascular Endothelial Growth Factor Expression
20%
Mindfulness-based Stress Reduction
18%
Epigenetic Mechanisms
18%
Program Effects
18%
Meditation
17%
Medicine and Dentistry
Malignant Neoplasm
100%
Systematic Review
84%
Multiple Chronic Conditions
56%
Care Coordination
56%
Primary Health Care
45%
Oncology
37%
Gut Microbiome
28%
Bevacizumab
28%
Mind-Body Interventions
28%
Lung Adenocarcinoma
28%
Cancer-Related Fatigue
28%
Xenograft
28%
Glucan
28%
Congestive Heart Failure
28%
Diseases
28%
Oncologist
26%
Quality of Life
22%
Vasculotropin
21%
Lung Cancer
21%
Cancer Therapy
18%
Randomized Controlled Trial
16%
Patient Care
12%
Combination Therapy
10%
Gene Expression
9%
Environmental Toxin
9%
Physical Activity
9%
Metabolite
9%
Sequela
9%
Gut Microbiota
9%
Metabolome
9%
Fatigue
9%
Public Health
9%
Microbiome
9%
DNA Sequence
9%
Side Effect
9%
Body Weight
9%
End of Life Care
9%
Cancer Prevention
9%
Counseling
9%
Gene Activity
9%
Heredity
9%
Biological Activity
9%
Tai Chi
8%
Yoga
8%
English (Language)
7%
Monoclonal Antibody
7%
Shared Care
7%